vs

Side-by-side financial comparison of Kimco Realty (KIM) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

Kimco Realty is the larger business by last-quarter revenue ($558.0M vs $321.1M, roughly 1.7× MADRIGAL PHARMACEUTICALS, INC.). Kimco Realty runs the higher net margin — 29.8% vs -18.2%, a 48.1% gap on every dollar of revenue. On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs 4.0%).

Kimco Realty Corporation, headquartered in Jericho, New York, is a real estate investment trust that invests in shopping centers.

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

KIM vs MDGL — Head-to-Head

Bigger by revenue
KIM
KIM
1.7× larger
KIM
$558.0M
$321.1M
MDGL
Growing faster (revenue YoY)
MDGL
MDGL
+206.8% gap
MDGL
210.8%
4.0%
KIM
Higher net margin
KIM
KIM
48.1% more per $
KIM
29.8%
-18.2%
MDGL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
KIM
KIM
MDGL
MDGL
Revenue
$558.0M
$321.1M
Net Profit
$166.3M
$-58.6M
Gross Margin
Operating Margin
37.2%
-18.6%
Net Margin
29.8%
-18.2%
Revenue YoY
4.0%
210.8%
Net Profit YoY
23.7%
1.4%
EPS (diluted)
$0.46
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KIM
KIM
MDGL
MDGL
Q1 26
$558.0M
Q4 25
$542.5M
$321.1M
Q3 25
$535.9M
$287.3M
Q2 25
$525.2M
$212.8M
Q1 25
$536.6M
$137.3M
Q4 24
$525.4M
$103.3M
Q3 24
$507.6M
$62.2M
Q2 24
$500.2M
Net Profit
KIM
KIM
MDGL
MDGL
Q1 26
$166.3M
Q4 25
$151.2M
$-58.6M
Q3 25
$137.8M
$-114.2M
Q2 25
$163.0M
$-42.3M
Q1 25
$132.8M
$-73.2M
Q4 24
$166.0M
$-59.4M
Q3 24
$136.0M
$-107.0M
Q2 24
$119.7M
Gross Margin
KIM
KIM
MDGL
MDGL
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
96.7%
Q4 24
Q3 24
Q2 24
Operating Margin
KIM
KIM
MDGL
MDGL
Q1 26
37.2%
Q4 25
36.4%
-18.6%
Q3 25
34.9%
-39.7%
Q2 25
39.2%
-22.2%
Q1 25
33.6%
-57.8%
Q4 24
31.7%
-64.8%
Q3 24
33.7%
-187.1%
Q2 24
32.1%
Net Margin
KIM
KIM
MDGL
MDGL
Q1 26
29.8%
Q4 25
27.9%
-18.2%
Q3 25
25.7%
-39.8%
Q2 25
31.0%
-19.9%
Q1 25
24.8%
-53.4%
Q4 24
31.6%
-57.5%
Q3 24
26.8%
-172.0%
Q2 24
23.9%
EPS (diluted)
KIM
KIM
MDGL
MDGL
Q1 26
$0.46
Q4 25
$-2.55
Q3 25
$-5.08
Q2 25
$-1.90
Q1 25
$-3.32
Q4 24
$-2.50
Q3 24
$-4.92
Q2 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KIM
KIM
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$198.7M
Total DebtLower is stronger
$339.9M
Stockholders' EquityBook value
$10.4B
$602.7M
Total Assets
$19.6B
$1.3B
Debt / EquityLower = less leverage
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KIM
KIM
MDGL
MDGL
Q1 26
Q4 25
$211.6M
$198.7M
Q3 25
$159.3M
$295.7M
Q2 25
$226.6M
$186.2M
Q1 25
$131.3M
$183.6M
Q4 24
$688.6M
$100.0M
Q3 24
$789.0M
$232.7M
Q2 24
$126.4M
Total Debt
KIM
KIM
MDGL
MDGL
Q1 26
Q4 25
$7.7B
$339.9M
Q3 25
$339.8M
Q2 25
$118.4M
Q1 25
$118.0M
Q4 24
$8.0B
$117.6M
Q3 24
$117.1M
Q2 24
Stockholders' Equity
KIM
KIM
MDGL
MDGL
Q1 26
$10.4B
Q4 25
$10.4B
$602.7M
Q3 25
$10.5B
$625.7M
Q2 25
$10.5B
$696.0M
Q1 25
$10.6B
$710.6M
Q4 24
$10.7B
$754.4M
Q3 24
$10.5B
$777.2M
Q2 24
$10.6B
Total Assets
KIM
KIM
MDGL
MDGL
Q1 26
$19.6B
Q4 25
$19.7B
$1.3B
Q3 25
$19.9B
$1.4B
Q2 25
$19.8B
$1.0B
Q1 25
$19.7B
$996.6M
Q4 24
$20.3B
$1.0B
Q3 24
$20.1B
$1.1B
Q2 24
$19.5B
Debt / Equity
KIM
KIM
MDGL
MDGL
Q1 26
Q4 25
0.74×
0.56×
Q3 25
0.54×
Q2 25
0.17×
Q1 25
0.17×
Q4 24
0.75×
0.16×
Q3 24
0.15×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KIM
KIM
MDGL
MDGL
Operating Cash FlowLast quarter
$-133.5M
Free Cash FlowOCF − Capex
$-133.8M
FCF MarginFCF / Revenue
-41.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KIM
KIM
MDGL
MDGL
Q1 26
Q4 25
$258.4M
$-133.5M
Q3 25
$332.4M
$79.8M
Q2 25
$305.4M
$-47.1M
Q1 25
$223.8M
$-88.9M
Q4 24
$239.5M
$-104.5M
Q3 24
$295.9M
$-67.0M
Q2 24
$294.1M
Free Cash Flow
KIM
KIM
MDGL
MDGL
Q1 26
Q4 25
$-133.8M
Q3 25
$79.0M
Q2 25
Q1 25
$205.4M
Q4 24
$-104.7M
Q3 24
$-67.8M
Q2 24
FCF Margin
KIM
KIM
MDGL
MDGL
Q1 26
Q4 25
-41.7%
Q3 25
27.5%
Q2 25
Q1 25
38.3%
Q4 24
-101.3%
Q3 24
-109.0%
Q2 24
Capex Intensity
KIM
KIM
MDGL
MDGL
Q1 26
Q4 25
0.0%
0.1%
Q3 25
0.0%
0.3%
Q2 25
0.0%
0.0%
Q1 25
3.4%
0.0%
Q4 24
0.2%
Q3 24
1.3%
Q2 24
Cash Conversion
KIM
KIM
MDGL
MDGL
Q1 26
Q4 25
1.71×
Q3 25
2.41×
Q2 25
1.87×
Q1 25
1.69×
Q4 24
1.44×
Q3 24
2.18×
Q2 24
2.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KIM
KIM

Revenues from rental properties, net$552.8M99%
Management and other fee income$5.2M1%

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons